4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-24-005208
VP Chief Financial Officer gave up 445 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hamm John M. VP Chief Financial Officer | 2024-03-23 | Shares withheld for taxes | −445 | $1.81 | $805 | 26,003 | D |
| Derivatives | |||||||
| Hamm John M. VP Chief Financial Officer | 2024-03-25 | Grant or award · Options (right to buy) | +5,500 | $1.71 | $9,405 | 12,500 | D |
Loading xslF345X05/marketforms-65389.xml…